Specific Diagnostic for Members of Genus Mycobacterium

Information

  • Research Project
  • 6933252
  • ApplicationId
    6933252
  • Core Project Number
    R43AI064969
  • Full Project Number
    1R43AI064969-01
  • Serial Number
    64969
  • FOA Number
  • Sub Project Id
  • Project Start Date
    6/1/2005 - 19 years ago
  • Project End Date
    2/28/2006 - 18 years ago
  • Program Officer Name
    JACOBS, GAIL G.
  • Budget Start Date
    6/1/2005 - 19 years ago
  • Budget End Date
    2/28/2006 - 18 years ago
  • Fiscal Year
    2005
  • Support Year
    1
  • Suffix
  • Award Notice Date
    3/22/2005 - 19 years ago
Organizations

Specific Diagnostic for Members of Genus Mycobacterium

DESCRIPTION (provided by applicant): A novel microarray-based system is proposed for diagnosis of tuberculosis and tuberculosis-like respiratory infections. This diagnostic system offers a parallel method to screen clinical samples for the presence of DNA sequences from Mycobacterium tuberculosis, the causative agent of human tuberculosis, and closely related mycobacterial species, while simultaneously screening specimens for more distantly related mycobacteria and other common infectious agents known to cause tuberculosis-like symptoms. The system selectively amplifies targeted DNA sequences using repeated rounds of primer-directed extension. Unlike the PCR, this method generates short extension products whose lengths are limited by using one of the building blocks in a form that terminates the extension reaction when it is incorporated. Restricting the extension reaction to the production of short extension products allows screening for many pathogens with a single reaction. The technique is very selective because a signal is produced only when the extension reaction products hybridize to probes immobilized on the microarray. This requires that: 1), the primer binds with a complementary sequence on the targeted DNA, and 2) the resulting short extension sequence is complementary to the probe on the microarray used to detect the extension product. Both of these are very selective processes.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R43
  • Administering IC
    AI
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    99998
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    856
  • Ed Inst. Type
  • Funding ICs
    NIAID:99998\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    ATOM SCIENCES, INC.
  • Organization Department
  • Organization DUNS
    048900880
  • Organization City
    OAK RIDGE
  • Organization State
    TN
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    378308810
  • Organization District
    UNITED STATES